Cargando…

Unprotected anal Intercourse among Iranian Intra-Venous Drug Users

Purpose: To assess the prevalence and associated factors of unprotected anal intercourse among Iranian male heterosexual Intra-Venous Drug Users (IDUs). Methods: In a cross-sectional study 360 male heterosexual IDUs were sampled from streets of eight different geographical parts of Iran. Variables s...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirabi, Parvaneh, Yarmohmmadi Vasel, Mosaieb, Moazen, Babak, Sehat, Mahmoud, Rezazadeh, Majid, Ahmadi, Khodabakhsh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859981/
https://www.ncbi.nlm.nih.gov/pubmed/24350203
http://dx.doi.org/10.3389/fpubh.2013.00034
_version_ 1782295482641416192
author Mirabi, Parvaneh
Yarmohmmadi Vasel, Mosaieb
Moazen, Babak
Sehat, Mahmoud
Rezazadeh, Majid
Ahmadi, Khodabakhsh
author_facet Mirabi, Parvaneh
Yarmohmmadi Vasel, Mosaieb
Moazen, Babak
Sehat, Mahmoud
Rezazadeh, Majid
Ahmadi, Khodabakhsh
author_sort Mirabi, Parvaneh
collection PubMed
description Purpose: To assess the prevalence and associated factors of unprotected anal intercourse among Iranian male heterosexual Intra-Venous Drug Users (IDUs). Methods: In a cross-sectional study 360 male heterosexual IDUs were sampled from streets of eight different geographical parts of Iran. Variables such as socio-demographics, HIV knowledge (10 items), and HIV attitude (16 items) were entered to a logistic regression to determine the predictors of unprotected anal intercourse during the past month. Results: From all, 20.8% reported unprotected anal intercourse during the past month. HIV knowledge was not significantly different among IDUs with and without unprotected anal intercourse. High age [odds ratio (OR) = 0.954, 95% confidence intervals (CI) = 0.916–0.992] was associated with a lower likelihood of unprotected anal intercourse, while being not married (OR = 2.301, 95% CI = 1.151–4.601), and high perceived HIV risk (OR = 1.776, 95% CI = 1.376–2.290) were associated with a higher likelihood of unprotected anal intercourse. Conclusion: Although the results might not be generalizable to all Iranian IDUs, this study findings may still be helpful for design and implementation of public health programs in Iran to prevent sexual transmission of HIV through IDUs.
format Online
Article
Text
id pubmed-3859981
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-38599812013-12-12 Unprotected anal Intercourse among Iranian Intra-Venous Drug Users Mirabi, Parvaneh Yarmohmmadi Vasel, Mosaieb Moazen, Babak Sehat, Mahmoud Rezazadeh, Majid Ahmadi, Khodabakhsh Front Public Health Public Health Purpose: To assess the prevalence and associated factors of unprotected anal intercourse among Iranian male heterosexual Intra-Venous Drug Users (IDUs). Methods: In a cross-sectional study 360 male heterosexual IDUs were sampled from streets of eight different geographical parts of Iran. Variables such as socio-demographics, HIV knowledge (10 items), and HIV attitude (16 items) were entered to a logistic regression to determine the predictors of unprotected anal intercourse during the past month. Results: From all, 20.8% reported unprotected anal intercourse during the past month. HIV knowledge was not significantly different among IDUs with and without unprotected anal intercourse. High age [odds ratio (OR) = 0.954, 95% confidence intervals (CI) = 0.916–0.992] was associated with a lower likelihood of unprotected anal intercourse, while being not married (OR = 2.301, 95% CI = 1.151–4.601), and high perceived HIV risk (OR = 1.776, 95% CI = 1.376–2.290) were associated with a higher likelihood of unprotected anal intercourse. Conclusion: Although the results might not be generalizable to all Iranian IDUs, this study findings may still be helpful for design and implementation of public health programs in Iran to prevent sexual transmission of HIV through IDUs. Frontiers Media S.A. 2013-09-26 /pmc/articles/PMC3859981/ /pubmed/24350203 http://dx.doi.org/10.3389/fpubh.2013.00034 Text en Copyright © 2013 Mirabi, Yarmohmmadi Vasel, Moazen, Sehat, Rezazadeh and Ahmadi. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Mirabi, Parvaneh
Yarmohmmadi Vasel, Mosaieb
Moazen, Babak
Sehat, Mahmoud
Rezazadeh, Majid
Ahmadi, Khodabakhsh
Unprotected anal Intercourse among Iranian Intra-Venous Drug Users
title Unprotected anal Intercourse among Iranian Intra-Venous Drug Users
title_full Unprotected anal Intercourse among Iranian Intra-Venous Drug Users
title_fullStr Unprotected anal Intercourse among Iranian Intra-Venous Drug Users
title_full_unstemmed Unprotected anal Intercourse among Iranian Intra-Venous Drug Users
title_short Unprotected anal Intercourse among Iranian Intra-Venous Drug Users
title_sort unprotected anal intercourse among iranian intra-venous drug users
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859981/
https://www.ncbi.nlm.nih.gov/pubmed/24350203
http://dx.doi.org/10.3389/fpubh.2013.00034
work_keys_str_mv AT mirabiparvaneh unprotectedanalintercourseamongiranianintravenousdrugusers
AT yarmohmmadivaselmosaieb unprotectedanalintercourseamongiranianintravenousdrugusers
AT moazenbabak unprotectedanalintercourseamongiranianintravenousdrugusers
AT sehatmahmoud unprotectedanalintercourseamongiranianintravenousdrugusers
AT rezazadehmajid unprotectedanalintercourseamongiranianintravenousdrugusers
AT ahmadikhodabakhsh unprotectedanalintercourseamongiranianintravenousdrugusers